Lineage Cell Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.

About LCTX

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.

CEO

Brian M. Culley

CEOBrian M. Culley

Employees

Employees77

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

1990

Founded1990

Employees

Employees77

LCTX Key Statistics

Market cap

111.41M

Market cap111.41M

Price-Earnings ratio

-5.04

Price-Earnings ratio-5.04

Dividend yield

—

Dividend yield—

Average volume

1.09M

Average volume1.09M

High today

$0.5138

High today$0.5138

Low today

$0.4647

Low today$0.4647

Open price

$0.4983

Open price$0.4983

Volume

814.63K

Volume814.63K

52 Week high

$1.40

52 Week high$1.40

52 Week low

$0.3651

52 Week low$0.3651

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell